Fitness Trackers During and After Oncological Treatments

Not Applicable

• Conditions: Fatigue; Physical Activity; Cancer
• Interventions: Device: Fitness Tracker

• Registration Number: NCT03610854
• Lead Sponsor: University Hospital Tuebingen

Brief Summary

The overall goal of the present trial is to evaluate the patients' compliance for wearing a commercially available fitness tracker during and after oncological treatments.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-04-18
• Status Verified: 2018-07
• Study First Submitted: 2018-07-16
• Study First Submitted QC: 2018-07-25
• Last Update Submitted: 2018-07-25
• Study First Posted: 2018-08-01
• Last Update Posted: 2018-08-01
• Primary Completion: 2018-12-31
• Study Completion: 2019-01-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Histologically confirmed malignant disease
• Upcoming chemotherapy of radiochemotherapy
• Eastern Co-operative Oncology Group (ECOG) performance score 0-2

Exclusion Criteria

• Pre-existing comorbidities that impair patient mobility.
• Eastern Co-operative Oncology Group (ECOG) performance score 3-4

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Fitness tracker Arm	Fitness Tracker	Patients will be wearing a commercially available fitness tracker during radiotherapy or chemotherapy and four weeks after the end of treatment.

Primary Outcome Measures

Name	Time	Method
Compliance for wearing the fitness tracker	Four weeks after the end of radiotherapy	Based on the read outs from the fitness trackers we will calculate the percentage of the days on which the tracker was worn, which is defined as the compliance.

Trial Locations

Locations (1)

University Hospital Tübingen; 🇩🇪 Tübingen, Germany